Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that Tony Carter has been appointed as an independent, non- executive director of the company effective 1 December 2010.
Chairman, Gary Paykel said, “We are extremely pleased to welcome Tony to the board and believe that his engineering background and considerable business experience will add to the strength of our board”.
Tony Carter has recently retired from his position as Managing Director of Foodstuffs New Zealand and will resign as Managing Director of Foodstuffs Auckland on 1 December 2010. He has been a non-executive director of Vector Limited since 2007, of Fletcher Building Limited since September this year and will join the Air New Zealand Limited board on 1 December 2010. Mr Carter is also a trustee of the Maurice Carter Charitable Trust. He received his Master of Engineering degree from the University of Canterbury, New Zealand, and a Master of Philosophy degree from Loughborough University of Technology, United Kingdom.
Fisher & Paykel Healthcare Corporation Limited also announce that Sir Colin Maiden has advised that he will retire from the board with effect from 22 February 2011.
Mr Paykel warmly thanked Sir Colin Maiden for his period of long service on the board, “Sir Colin joined the board of Fisher & Paykel in 1978, went on to serve as chairman for 12 years and oversaw the reorganisation and separation of Fisher & Paykel Healthcare in 2001. He has made an outstanding contribution to the company during his 32 years as a director and as a longstanding member of the Audit & Risk, Nomination and Remuneration Committees. We wish him all the best for the future”.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company visit www.fphcare.com
Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.
Fisher & Paykel Healthcare Announces Changes to Board of Directors
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice